Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
More high-quality evidence is needed to determine how this class of HIV medications may affect weight gain.
A review of the major findings presented at the Annual Meeting of the American Association for the Study of Liver Diseases in San Francisco
The tablet from the South Korean company Celltrion contains tenofovir disoproxil fumarate and lamivudine.
Researchers call for closer cardiovascular monitoring for those switching from the TDF form of the drug to the TAF version.
Among those taking Epivir, taking two antiretrovirals instead of three was tied to fewer people stopping because of side effects.
Nevertheless, researchers advise careful kidney monitoring when pairing the medications.
Most of such drug resistance seen is to older drugs.
That’s compared with HIV-negative men.
A new analysis finds that Gilead Sciences’ updated version of its key antiretroviral tenofovir may not actually offer any safety benefits.
Additionally, in a recent study, having hep C mutations associated with resistance didn’t affect the outcome of treatment.
A recent study analyzed kidney parameters among those with HIV who were treated for hep C with the regimen.
With a grant to follow their large study population through 2021, researchers hope to gain vital new insights about HIV infection.
Largest-ever analysis of bone loss in the HIV population found that treating hep C, taking vitamin D and exercising might be preventive.
The new drug application is for doravirine as both an individual tablet and part of a combination tablet.
An anti-HIV vaginal microbicide gel lowered risk among women with a healthier dominant bacterial population.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.